CDER New November 23, 2015

FDA (U.S. Food and Drug Administration)

Searching the Orange Book is now faster and easier with our new mobile app!

Download Orange Book Express

 Download iOS App Download Android App Black

What's New on the FDA Drugs Site

 

November 20, 2015


New and Generic Drug Approvals

November 18, 2015

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Edarbyclor azilsartan kamedoxomil; chlorthalidone Tablet;Oral Arbor Pharms Ireland Manufacturing Change or Addition
Halaven eribulin mesylate Solution;Intravenous Eisai Inc Manufacturing Change or Addition
Narcan naloxone hydrochloride Spray;Nasal Adapt Approval
Omnicef cefdinir Capsule;Oral Abbvie Labeling Revision
Omnicef cefdinir For Suspension;Oral Abbvie Labeling Revision
Trilipix choline fenofibrate Capsule, Delayed Release;Oral Abbvie Manufacturing Change or Addition
Viread tenofovir disoproxil fumarate Tablet;Oral Gilead Sciences Inc Manufacturing Change or Addition

 


This email was sent to rssproject471@gmail.com using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery

Postingan terkait:

Belum ada tanggapan untuk "CDER New November 23, 2015"

Post a Comment